Global Enterobacteriaceae Infection Drug Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Enterobacteriaceae Infection Drug Market Size 2017-2028

2.1.2 Enterobacteriaceae Infection Drug Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Enterobacteriaceae Infection Drug Segment by Type

2.2.1 Beta-lactams Drugs

2.2.2 Carbapenems Drugs

2.2.3 Fluoroquinolones Drugs

2.2.4 Others

2.3 Enterobacteriaceae Infection Drug Market Size by Type

2.3.1 Enterobacteriaceae Infection Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2022)

2.4 Enterobacteriaceae Infection Drug Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Enterobacteriaceae Infection Drug Market Size by Application

2.5.1 Enterobacteriaceae Infection Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2022)

3 Enterobacteriaceae Infection Drug Market Size by Player

3.1 Enterobacteriaceae Infection Drug Market Size Market Share by Players

3.1.1 Global Enterobacteriaceae Infection Drug Revenue by Players (2020-2022)

3.1.2 Global Enterobacteriaceae Infection Drug Revenue Market Share by Players (2020-2022)

3.2 Global Enterobacteriaceae Infection Drug Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Enterobacteriaceae Infection Drug by Regions

4.1 Enterobacteriaceae Infection Drug Market Size by Regions (2017-2022)

4.2 Americas Enterobacteriaceae Infection Drug Market Size Growth (2017-2022)

4.3 APAC Enterobacteriaceae Infection Drug Market Size Growth (2017-2022)

4.4 Europe Enterobacteriaceae Infection Drug Market Size Growth (2017-2022)

4.5 Middle East & Africa Enterobacteriaceae Infection Drug Market Size Growth (2017-2022)

5 Americas

5.1 Americas Enterobacteriaceae Infection Drug Market Size by Country (2017-2022)

5.2 Americas Enterobacteriaceae Infection Drug Market Size by Type (2017-2022)

5.3 Americas Enterobacteriaceae Infection Drug Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Enterobacteriaceae Infection Drug Market Size by Region (2017-2022)

6.2 APAC Enterobacteriaceae Infection Drug Market Size by Type (2017-2022)

6.3 APAC Enterobacteriaceae Infection Drug Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Enterobacteriaceae Infection Drug by Country (2017-2022)

7.2 Europe Enterobacteriaceae Infection Drug Market Size by Type (2017-2022)

7.3 Europe Enterobacteriaceae Infection Drug Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Enterobacteriaceae Infection Drug by Region (2017-2022)

8.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2017-2022)

8.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Enterobacteriaceae Infection Drug Market Forecast

10.1 Global Enterobacteriaceae Infection Drug Forecast by Regions (2023-2028)

10.1.1 Global Enterobacteriaceae Infection Drug Forecast by Regions (2023-2028)

10.1.2 Americas Enterobacteriaceae Infection Drug Forecast

10.1.3 APAC Enterobacteriaceae Infection Drug Forecast

10.1.4 Europe Enterobacteriaceae Infection Drug Forecast

10.1.5 Middle East & Africa Enterobacteriaceae Infection Drug Forecast

10.2 Americas Enterobacteriaceae Infection Drug Forecast by Country (2023-2028)

10.2.1 United States Enterobacteriaceae Infection Drug Market Forecast

10.2.2 Canada Enterobacteriaceae Infection Drug Market Forecast

10.2.3 Mexico Enterobacteriaceae Infection Drug Market Forecast

10.2.4 Brazil Enterobacteriaceae Infection Drug Market Forecast

10.3 APAC Enterobacteriaceae Infection Drug Forecast by Region (2023-2028)

10.3.1 China Enterobacteriaceae Infection Drug Market Forecast

10.3.2 Japan Enterobacteriaceae Infection Drug Market Forecast

10.3.3 Korea Enterobacteriaceae Infection Drug Market Forecast

10.3.4 Southeast Asia Enterobacteriaceae Infection Drug Market Forecast

10.3.5 India Enterobacteriaceae Infection Drug Market Forecast

10.3.6 Australia Enterobacteriaceae Infection Drug Market Forecast

10.4 Europe Enterobacteriaceae Infection Drug Forecast by Country (2023-2028)

10.4.1 Germany Enterobacteriaceae Infection Drug Market Forecast

10.4.2 France Enterobacteriaceae Infection Drug Market Forecast

10.4.3 UK Enterobacteriaceae Infection Drug Market Forecast

10.4.4 Italy Enterobacteriaceae Infection Drug Market Forecast

10.4.5 Russia Enterobacteriaceae Infection Drug Market Forecast

10.5 Middle East & Africa Enterobacteriaceae Infection Drug Forecast by Region (2023-2028)

10.5.1 Egypt Enterobacteriaceae Infection Drug Market Forecast

10.5.2 South Africa Enterobacteriaceae Infection Drug Market Forecast

10.5.3 Israel Enterobacteriaceae Infection Drug Market Forecast

10.5.4 Turkey Enterobacteriaceae Infection Drug Market Forecast

10.5.5 GCC Countries Enterobacteriaceae Infection Drug Market Forecast

10.6 Global Enterobacteriaceae Infection Drug Forecast by Type (2023-2028)

10.7 Global Enterobacteriaceae Infection Drug Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Genentech

11.1.1 Genentech Company Information

11.1.2 Genentech Enterobacteriaceae Infection Drug Product Offered

11.1.3 Genentech Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Genentech Main Business Overview

11.1.5 Genentech Latest Developments

11.2 Nanotherapeutics

11.2.1 Nanotherapeutics Company Information

11.2.2 Nanotherapeutics Enterobacteriaceae Infection Drug Product Offered

11.2.3 Nanotherapeutics Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Nanotherapeutics Main Business Overview

11.2.5 Nanotherapeutics Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Enterobacteriaceae Infection Drug Product Offered

11.3.3 Novartis Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Pfizer

11.4.1 Pfizer Company Information

11.4.2 Pfizer Enterobacteriaceae Infection Drug Product Offered

11.4.3 Pfizer Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Pfizer Main Business Overview

11.4.5 Pfizer Latest Developments

11.5 Nymox Pharmaceutical

11.5.1 Nymox Pharmaceutical Company Information

11.5.2 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product Offered

11.5.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Nymox Pharmaceutical Main Business Overview

11.5.5 Nymox Pharmaceutical Latest Developments

11.6 Sequoia Sciences

11.6.1 Sequoia Sciences Company Information

11.6.2 Sequoia Sciences Enterobacteriaceae Infection Drug Product Offered

11.6.3 Sequoia Sciences Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Sequoia Sciences Main Business Overview

11.6.5 Sequoia Sciences Latest Developments

11.7 Phico Therapeutics

11.7.1 Phico Therapeutics Company Information

11.7.2 Phico Therapeutics Enterobacteriaceae Infection Drug Product Offered

11.7.3 Phico Therapeutics Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Phico Therapeutics Main Business Overview

11.7.5 Phico Therapeutics Latest Developments

11.8 Cantab Biopharmaceuticals

11.8.1 Cantab Biopharmaceuticals Company Information

11.8.2 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Product Offered

11.8.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Cantab Biopharmaceuticals Main Business Overview

11.8.5 Cantab Biopharmaceuticals Latest Developments

12 Research Findings and Conclusion

Table 1. Enterobacteriaceae Infection Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Beta-lactams Drugs

Table 3. Major Players of Carbapenems Drugs

Table 4. Major Players of Fluoroquinolones Drugs

Table 5. Major Players of Others

Table 6. Enterobacteriaceae Infection Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2022)

Table 9. Enterobacteriaceae Infection Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2022)

Table 12. Global Enterobacteriaceae Infection Drug Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Enterobacteriaceae Infection Drug Revenue Market Share by Player (2020-2022)

Table 14. Enterobacteriaceae Infection Drug Key Players Head office and Products Offered

Table 15. Enterobacteriaceae Infection Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Enterobacteriaceae Infection Drug Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Enterobacteriaceae Infection Drug Market Size Market Share by Regions (2017-2022)

Table 20. Americas Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Enterobacteriaceae Infection Drug Market Size Market Share by Country (2017-2022)

Table 22. Americas Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2022)

Table 24. Americas Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2022)

Table 26. APAC Enterobacteriaceae Infection Drug Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Enterobacteriaceae Infection Drug Market Size Market Share by Region (2017-2022)

Table 28. APAC Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2022)

Table 30. APAC Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2022)

Table 32. Europe Enterobacteriaceae Infection Drug Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Country (2017-2022)

Table 34. Europe Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2022)

Table 36. Europe Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Enterobacteriaceae Infection Drug

Table 45. Key Market Challenges & Risks of Enterobacteriaceae Infection Drug

Table 46. Key Industry Trends of Enterobacteriaceae Infection Drug

Table 47. Global Enterobacteriaceae Infection Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Enterobacteriaceae Infection Drug Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Enterobacteriaceae Infection Drug Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Enterobacteriaceae Infection Drug Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Enterobacteriaceae Infection Drug Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Enterobacteriaceae Infection Drug Market Size Market Share Forecast by Application (2023-2028)

Table 53. Genentech Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors

Table 54. Genentech Enterobacteriaceae Infection Drug Product Offered

Table 55. Genentech Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Genentech Main Business

Table 57. Genentech Latest Developments

Table 58. Nanotherapeutics Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors

Table 59. Nanotherapeutics Enterobacteriaceae Infection Drug Product Offered

Table 60. Nanotherapeutics Main Business

Table 61. Nanotherapeutics Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Nanotherapeutics Latest Developments

Table 63. Novartis Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors

Table 64. Novartis Enterobacteriaceae Infection Drug Product Offered

Table 65. Novartis Main Business

Table 66. Novartis Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Novartis Latest Developments

Table 68. Pfizer Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors

Table 69. Pfizer Enterobacteriaceae Infection Drug Product Offered

Table 70. Pfizer Main Business

Table 71. Pfizer Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Pfizer Latest Developments

Table 73. Nymox Pharmaceutical Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors

Table 74. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product Offered

Table 75. Nymox Pharmaceutical Main Business

Table 76. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Nymox Pharmaceutical Latest Developments

Table 78. Sequoia Sciences Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors

Table 79. Sequoia Sciences Enterobacteriaceae Infection Drug Product Offered

Table 80. Sequoia Sciences Main Business

Table 81. Sequoia Sciences Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Sequoia Sciences Latest Developments

Table 83. Phico Therapeutics Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors

Table 84. Phico Therapeutics Enterobacteriaceae Infection Drug Product Offered

Table 85. Phico Therapeutics Main Business

Table 86. Phico Therapeutics Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Phico Therapeutics Latest Developments

Table 88. Cantab Biopharmaceuticals Details, Company Type, Enterobacteriaceae Infection Drug Area Served and Its Competitors

Table 89. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Product Offered

Table 90. Cantab Biopharmaceuticals Main Business

Table 91. Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Cantab Biopharmaceuticals Latest Developments

List of Figures

Figure 1. Enterobacteriaceae Infection Drug Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Enterobacteriaceae Infection Drug Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Enterobacteriaceae Infection Drug Market Size Market Share by Type in 2021

Figure 7. Enterobacteriaceae Infection Drug in Hospital Pharmacies

Figure 8. Global Enterobacteriaceae Infection Drug Market: Hospital Pharmacies (2017-2022) & ($ Millions)

Figure 9. Enterobacteriaceae Infection Drug in Retail Pharmacies

Figure 10. Global Enterobacteriaceae Infection Drug Market: Retail Pharmacies (2017-2022) & ($ Millions)

Figure 11. Enterobacteriaceae Infection Drug in Online Pharmacies

Figure 12. Global Enterobacteriaceae Infection Drug Market: Online Pharmacies (2017-2022) & ($ Millions)

Figure 13. Global Enterobacteriaceae Infection Drug Market Size Market Share by Application in 2021

Figure 14. Global Enterobacteriaceae Infection Drug Revenue Market Share by Player in 2021

Figure 15. Global Enterobacteriaceae Infection Drug Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Enterobacteriaceae Infection Drug Market Size 2017-2022 ($ Millions)

Figure 17. APAC Enterobacteriaceae Infection Drug Market Size 2017-2022 ($ Millions)

Figure 18. Europe Enterobacteriaceae Infection Drug Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Enterobacteriaceae Infection Drug Market Size 2017-2022 ($ Millions)

Figure 20. Americas Enterobacteriaceae Infection Drug Value Market Share by Country in 2021

Figure 21. Americas Enterobacteriaceae Infection Drug Consumption Market Share by Type in 2021

Figure 22. Americas Enterobacteriaceae Infection Drug Market Size Market Share by Application in 2021

Figure 23. United States Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Enterobacteriaceae Infection Drug Market Size Market Share by Region in 2021

Figure 28. APAC Enterobacteriaceae Infection Drug Market Size Market Share by Application in 2021

Figure 29. China Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Country in 2021

Figure 36. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Type in 2021

Figure 37. Europe Enterobacteriaceae Infection Drug Market Size Market Share by Application in 2021

Figure 38. Germany Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Enterobacteriaceae Infection Drug Market Size Market Share by Application in 2021

Figure 46. Egypt Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Enterobacteriaceae Infection Drug Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 52. APAC Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 53. Europe Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 55. United States Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 56. Canada Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 59. China Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 60. Japan Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 61. Korea Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 63. India Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 64. Australia Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 65. Germany Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 66. France Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 67. UK Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 68. Italy Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 69. Russia Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 70. Spain Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 73. Israel Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Enterobacteriaceae Infection Drug Market Size 2023-2028 ($ Millions)